Dynacare will discontinue the current testing methodology of radioimmunoassay (RIA) for these analytes. Acetylcholine receptor antibody will transition to enzyme linked immunoassay (ELISA) testing, and both leptin and insulin antibody testing will be referred out. Reference intervals for referred out testing will be provided by the testing laboratory.
Read More: Changes to acetylcholine receptor antibody, leptin and insulin antibody testing